Strategic Financing Strong recent funding from EIB (€20M) and recent $23.5–$23.9M financing signals validation and resources to expand sales efforts, especially in Europe with planned US market entry.

Market Expansion Expansion of European commercial operations and planned US market entry create opportunities to target hospital networks, surgical centers, and pathology labs across multiple geographies requiring real-time intraoperative imaging.

Product Advantage CE marked and FDA cleared Histolog Scanner positions the company for direct hospital procurement, enabling selling points around speed, intraoperative decision support, and improved surgical outcomes.

Clinical Validation Invested funding coincides with clinical results and rapid tissue imaging capabilities, offering compelling case studies and ROI proof to drive expansion into top-tier surgical and diagnostic centers.

Enterprise Tech Stack Existing integrations with enterprise platforms (HubSpot, SharePoint, Intune) and digital imaging tech suggest cross-sell opportunities with hospital IT, data management, and compliance teams for deployment and lifecycle services.